Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1783 of 5804
-
Kidney stone breakthrough? urine pH may predict shock wave success
Disease control Ongoingurolethiasis (kidney stones) is common globally, with recurrence in 50% of patients. * Shock Wave Lithotripsy (SWL) is a minimally invasive treatment for stones \< 2 cm. * Hypothesis: Urine pH might influence SWL success and could be manipulated pre-procedure. Aim of the work is…
Phase: NA • Sponsor: Benha University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New study tracks hidden dangers of CAR t therapy in kids
Knowledge-focused Recruiting nowThis study is being done to learn more about the short-term and long-term side effects of CAR-T cell therapy. Specifically, researchers want to know how often patients get infections, have delays in recovering blood cell counts and/or have damage to the nervous system.
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New custom lens aims to sharpen vision for those with tricky eye shapes
Disease control Recruiting nowCataract surgery in patients with irregular corneas presents unique challenges, primarily due to the high variability in keratometry and corneal tomography measurements, which complicates accurate intraocular lens (IOL) calculations. In these patients, therapeutic options are cur…
Phase: NA • Sponsor: Johannes Kepler University of Linz • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New CT scanner could spot hidden liver cancer after treatment
Diagnosis Recruiting nowBy comparing the diagnostic accuracy of spectral CT and conventional CT in evaluating treatment response efficacy after TACE, this study aims to investigate the diagnostic performance of spectral CT in assessing treatment response following TACE for hepatocellular carcinoma.
Sponsor: Zhongda Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:08 UTC
-
Can a phone app cure your sleepless nights? new trial tests digital CBT vs. pills
Symptom relief Recruiting nowThe purpose of this study is to evaluate the clinical and cost-effectiveness of an intelligent therapy based on digital cognitive behavioral therapy for insomnia disorders
Phase: NA • Sponsor: Zan Wang • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Brain zaps for schizophrenia? tiny trial tests DBS when meds fail
Disease control Not yet recruitingSchizophrenia is a lifelong psychiatric disorder with a prevalence rate of 0.559% and a lifetime prevalence rate of 0.588% among Chinese adults. It often causes social dysfunction and psychiatric disability, shortening patients' life expectancy by 10-25 years compared to the gene…
Phase: NA • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Night-Shift workers test gut bug and herb combo to beat diabetes risk
Disease control Recruiting nowNight shift work is associated with an increased risk of obesity, insulin resistance, and cardiometabolic disorders, largely due to circadian misalignment, disrupted sleep, and altered eating patterns. These behavioral and physiological disturbances impair glucose metabolism and …
Phase: NA • Sponsor: FH Joanneum Gesellschaft mbH • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Lifestyle overhaul tested as fatty liver fix
Disease control Recruiting nowOverall design: The study will include one intervention based on Mediterranean diet plus structured lifestyle intervention (150 min/week of moderate-intensity or 75 min/week of high-intensity exercise) for a total of 16 weeks. Following a screening period of up to 12 months, elig…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Brain implant aims to forecast seizures in Drug-Resistant epilepsy
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate the safety and feasibility of using seizure forecasts based on subscalp EEG.
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
ER chatbot aims to cut fall injuries in seniors
Prevention Recruiting nowFalls are the leading reason for injury-related emergency department (ED) visits in older adults with high rates of ED revisits for falls. Evidence-based fall prevention programs can reduce falls by 30%, but older adults commonly describe limited awareness of resources. Currently…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
WhatsApp therapy could boost stroke hand recovery
Symptom relief OngoingStroke is a leading cause of adult disability worldwide, with upper limb impairment significantly reducing independence. Traditional outpatient rehabilitation poses challenges for patients with mobility limitations, financial constraints, or those living in remote areas. This ran…
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New ventilator strategy aims to help ICU patients breathe easier
Disease control Recruiting nowThe Inspiratory effort-Targeted Pressure Support Ventilation (IT-PSV) is a cluster randomized controlled trial. Its main aim is to determine whether an inspiratory effort-targeted pressure support setting strategy, compared to the traditional tidal volume and respiratory rate tar…
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Lower dose of olanzapine may ease chemo nausea with less drowsiness
Symptom relief CompletedOlanzapine is an effective antiemetic agent for preventing highly emetogenic regimens-induced nausea and vomiting (HER-INV) in patients receiving highly emetogenic regimens (HER). The optimal dose remains debated, with the standard 10 mg dose often causing significant daytime sed…
Sponsor: Shandong Cancer Hospital and Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Keyhole surgery vs. open surgery for pancreatic cancer: which is safer?
Disease control Recruiting nowThis is a monocentric, prospective, randomized controlled trial comparing the safety and efficacy of laparoscopic pancreaticoduodenectomy (LPD) versus open pancreaticoduodenectomy (OPD). The study aims to determine the morbimortality of the laparoscopic approach compared to the g…
Phase: NA • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Thyroid study aims to spare patients from unnecessary surgery and lifelong pills
Disease control Recruiting nowThe traditional surgical approach for Bethesda IV thyroid nodules burdens healthcare systems and patients with costs, perioperative morbidity, and potential long-term consequences of hemithyroidectomy, including hypothyroidism (requiring lifelong thyroid hormone replacement), ner…
Phase: NA • Sponsor: Christian Grønhøj Larsen • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for advanced cancer: MHB048C enters human trials
Disease control Recruiting nowThis is a first-in-human, open-label, multicenter Phase I/II study of MHB048C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB048C monotherapy.
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Butter and bacon for a stronger heart? new trial puts high-fat diet to the test.
Disease control Recruiting nowHeart failure (HF) continues to be a leading cause of morbidity and mortality worldwide, despite advances in treatment. HF is often characterized by an altered metabolism in the heart, where glucose is favored over fatty acids as the primary energy substrate. This metabolic shift…
Phase: NA • Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New CAR-T therapy targets Hard-to-Treat myeloma
Disease control Not yet recruitingThis study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection(In Vivo CAR-T) in Patients with Relapsed/Refractory Multiple Myeloma
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
AI matches dermatologists in skin cancer diagnosis study
Diagnosis OngoingThe goal of this observational study is to evaluate the diagnostic accuracy of a CNN-based artificial intelligence model in patients with solitary skin lesions. The main questions it aims to answer are: * What is the diagnostic performance (sensitivity and specificity) of the CN…
Sponsor: Istanbul Training and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Breast cancer drug tamoxifen tested as new hope for cystic fibrosis
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety and tolerability of TMX in adults patients with cystic fibrosis who do not have mutations currently eligible for therapy with modulator drugs. The main questions it aims to answer is: . What medical problems do participa…
Phase: PHASE2 • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC